KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Goodwill (2016 - 2025)

Opko Health (OPK) has disclosed Goodwill for 16 consecutive years, with $484.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill fell 8.5% year-over-year to $484.3 million, compared with a TTM value of $484.3 million through Dec 2025, down 8.5%, and an annual FY2025 reading of $484.3 million, down 8.5% over the prior year.
  • Goodwill was $484.3 million for Q4 2025 at Opko Health, roughly flat from $484.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $710.4 million in Q4 2021 and bottomed at $476.7 million in Q1 2025.
  • Average Goodwill over 5 years is $571.4 million, with a median of $573.5 million recorded in 2022.
  • The sharpest move saw Goodwill increased 4.38% in 2021, then fell 11.53% in 2024.
  • Year by year, Goodwill stood at $710.4 million in 2021, then dropped by 10.77% to $633.9 million in 2022, then decreased by 5.62% to $598.3 million in 2023, then decreased by 11.53% to $529.3 million in 2024, then decreased by 8.5% to $484.3 million in 2025.
  • Business Quant data shows Goodwill for OPK at $484.3 million in Q4 2025, $484.0 million in Q3 2025, and $484.2 million in Q2 2025.